Medtech mergers stayed strong in Q3

November 12, 2014 by Brad Perriello

Merger & acquisition activity in the medtech sector stayed strong during the 3rd quarter, according to PricewaterhouseCoopers.

The merger & acquisition frenzy that consumed the medical device industry during the 2nd quarter stayed strong during the ensuing period, although the value of the Q3 deals slipped a bit, according to PricewaterhouseCoopers.

Medtech posted more deals during Q3, going from 11 to 13 deals on a sequential-quarter basis, according to PwC’s Pharmaceutical & Life Sciences Deals Insights Quarterly.

But the value of the deals declined from $5.6 billion to $3.6 billion during the 3rd quarter, compared with Q2, and slid 38.1% from Q3 2013, according to the report.



Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *